Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
21.4%
% of PBE's 28 holdings also in GNOM
14.6%
% of GNOM's 41 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
BIO-TECHNE CORPORATION | 4.8% | 3.4% | 3.4% |
|
BIOMARIN PHARMACEUTICAL INC | 5.0% | 3.3% | 3.3% |
|
MYRIAD GENETICS INC | 2.4% | 2.7% | 2.4% |
|
VERACYTE INC | 2.2% | 2.5% | 2.2% |
|
VERTEX PHARMACEUTICALS INC | 4.9% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to GNOM
|
NEUROCRINE BIOSCIENCES INC | 5.3% |
|
REGENERON PHARMACEUTICALS | 5.1% |
|
AMGEN INC | 4.8% |
|
BIOGEN IDEC INC | 4.7% |
|
GILEAD SCIENCES INC | 3.6% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
|
HALOZYME THERAPEUTICS INC | 3.2% |
|
EXELIXIS INC | 3.1% |
|
CATALYST PHARMACEUTICAL PART | 3.1% |
PBE Underweight Relative to GNOM
|
NATERA INC | -7.4% |
 |
ENI SPA-SPONSORED ADR | -7.2% |
|
CRISPR THERAPEUTICS AG | -4.9% |
|
ULTRAGENYX PHARMACEUTICAL IN | -4.7% |
|
AGILENT TECHNOLOGIES INC | -4.3% |
|
MODERNA, INC. | -4.1% |
|
SAREPTA THERAPEUTICS INC | -3.6% |
|
ILLUMINA INC | -3.5% |
|
QIAGEN NV | -3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.3% |